IFM Investors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $32.1M | Buy |
1,334,837
+105,357
| +9% | +$2.76M | 0.21% | 79 |
|
|
2026
Q1 | $34.5M | Buy |
1,229,480
+54,721
| +5% | +$1.46M | 0.29% | 67 |
|
|
2025
Q4 | $29.3M | Buy |
1,174,759
+45,828
| +4% | +$1.16M | 0.24% | 81 |
|
|
2025
Q3 | $26.8M | Buy |
1,128,931
+1,788
| +0.2% | +$44.1K | 0.24% | 82 |
|
|
2025
Q2 | $27.3M | Buy |
1,127,143
+41,263
| +4% | +$962K | 0.26% | 74 |
|
|
2025
Q1 | $27.5M | Sell |
1,085,880
-2,329
| -0.2% | -$60.9K | 0.3% | 65 |
|
|
2024
Q4 | $28.9M | Sell |
1,088,209
-90,190
| -8% | -$2.45M | 0.29% | 59 |
|
|
2024
Q3 | $34.1M | Sell |
1,178,399
-873
| -0.1% | -$25.5K | 0.33% | 56 |
|
|
2024
Q2 | $33M | Buy |
1,179,272
+18,463
| +2% | +$508K | 0.33% | 53 |
|
|
2024
Q1 | $32.2M | Buy |
1,160,809
+4,393
| +0.4% | +$122K | 0.35% | 52 |
|
|
2023
Q4 | $33.3M | Sell |
1,156,416
-1,746
| -0.2% | -$52.8K | 0.41% | 45 |
|
|
2023
Q3 | $38.4M | Buy |
1,158,162
+35,484
| +3% | +$1.25M | 0.51% | 32 |
|
|
2023
Q2 | $41.2M | Buy |
1,122,678
+70,975
| +7% | +$2.76M | 0.54% | 32 |
|
|
2023
Q1 | $42.9M | Buy |
1,051,703
+27,578
| +3% | +$1.19M | 0.65% | 25 |
|
|
2022
Q4 | $52.5M | Buy |
1,024,125
+58,601
| +6% | +$2.81M | 0.88% | 19 |
|
|
2022
Q3 | $42.3M | Buy |
965,524
+22,746
| +2% | +$1.11M | 0.77% | 21 |
|
|
2022
Q2 | $49.4M | Buy |
942,778
+64,745
| +7% | +$3.3M | 0.87% | 16 |
|
|
2022
Q1 | $45.5M | Buy |
878,033
+153,642
| +21% | +$7.97M | 0.71% | 23 |
|
|
2021
Q4 | $42.8M | Buy |
+724,391
| New | +$35.9M | 0.78% | 17 |
|
|
2021
Q3 | – | Sell |
-732,247
| Closed | -$28.7M | – | 592 |
|
|
2021
Q2 | $28.7M | Buy |
732,247
+134,309
| +22% | +$5.22M | 0.59% | 28 |
|
|
2021
Q1 | $21.7M | Buy |
597,938
+60,557
| +11% | +$2.15M | 0.58% | 30 |
|
|
2020
Q4 | $19.8M | Buy |
537,381
+50,188
| +10% | +$1.84M | 0.63% | 29 |
|
|
2020
Q3 | $17M | Buy |
487,193
+57,666
| +13% | +$2.02M | 0.71% | 26 |
|
|
2020
Q2 | $13.3M | Sell |
429,527
-154,505
| -26% | -$5.25M | 0.69% | 29 |
|
|
2020
Q1 | $18.1M | Sell |
584,032
-19,461
| -3% | -$663K | 0.81% | 21 |
|
|
2019
Q4 | $22.4M | Sell |
603,493
-30,117
| -5% | -$1.07M | 0.79% | 25 |
|
|
2019
Q3 | $21.6M | Buy |
633,610
+218,001
| +52% | +$7.93M | 0.8% | 28 |
|
|
2019
Q2 | $17.1M | Buy |
415,609
+19,058
| +5% | +$757K | 0.97% | 17 |
|
|
2019
Q1 | $16M | Buy |
396,551
+38,556
| +11% | +$1.54M | 1.03% | 14 |
|
|
2018
Q4 | $14.8M | Buy |
357,995
+32,426
| +10% | +$1.35M | 1.2% | 11 |
|
|
2018
Q3 | $13.6M | Buy |
325,569
+41,523
| +15% | +$1.6M | 1.03% | 13 |
|
|
2018
Q2 | $9.78M | Buy |
284,046
+88,507
| +45% | +$3.02M | 0.92% | 19 |
|
|
2018
Q1 | $6.58M | Buy |
195,539
+19,704
| +11% | +$677K | 0.95% | 18 |
|
|
2017
Q4 | $6.04M | Sell |
175,835
-668
| -0.4% | -$22.8K | 0.95% | 19 |
|
|
2017
Q3 | $5.98M | Buy |
176,503
+3,228
| +2% | +$104K | 1.01% | 16 |
|
|
2017
Q2 | $5.52M | Buy |
173,275
+43,316
| +33% | +$1.37M | 0.99% | 16 |
|
|
2017
Q1 | $4.22M | Buy |
129,959
+48,482
| +60% | +$1.53M | 1.07% | 15 |
|
|
2016
Q4 | $2.51M | Buy |
+81,477
| New | +$2.49M | 1.18% | 17 |
|
Other funds holding PFE
IFM Investors's PFE Position: Q2 2026 in Review
IFM Investors increased its Pfizer (PFE) stake by 8.6% in Q2 2026, buying an estimated $2.76M and bringing the position to 1,334,837 shares worth $32.1M. The position accounts for 0.21% of the portfolio, ranked #79.
IFM Investors first reported a position in PFE in Q4 2016 and has held it in 38 quarters since. The position peaked at $52.5M in Q4 2022. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- IFM Investors held 1,334,837 shares of Pfizer worth $32.1M as of Q2 2026.
- IFM Investors bought 105,357 Pfizer shares in Q2 2026, an estimated $2.76M.
- Pfizer made up 0.21% of IFM Investors's portfolio in Q2 2026, its #79 holding.
- IFM Investors first reported a position in Pfizer in Q4 2016 and has held it in 38 quarters since.
- IFM Investors's Pfizer position peaked at $52.5M in Q4 2022.
- 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on IFM Investors's 13F filing for Q2 2026, filed 21 Jul 2026.